Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by eleva GmbH

Eleva advances CPV-104 into Phase 1b clinical testing in patients with C3G, following the successful completion of single ascending dose evaluation in healthy volunteers
From eleva GmbH
Via GlobeNewswire
Eleva administers first dose of its Factor H biological treatment in C3-Glomerulopathy to healthy volunteers
From eleva GmbH
Via GlobeNewswire
Eleva Appoints Donato Spota as Chief Financial Officer
From eleva GmbH
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.